All In Biotech

NDA 019631 · B Braun

Dextrose 5% and Sodium Chloride 0.11% In Plastic Container

Dextrose, Sodium Chloride · Injection

Last checked: Nov 20, 2026Latest source record: Sep 29, 2026 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1988

Feb 24, 1988

Approved uses

1

Original approval plus efficacy supplements

Registered trials

3,797

712 Phase 3, 359 recruiting

FAERS reports

167

157 serious, 58 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Sep 28, 2026.

Dextrose and Sodium Chloride Injection is indicated as a source of water, electrolytes, and calories in adults and pediatric patients. Dextrose and Sodium Chloride Injection is indicated as a source of water, electrolytes, and calories in adults and pediatric patients.

Mechanism: Dextrose is a source of carbohydrate calories and is used to supplement nutrition by providing glucose parenterally. Sodium Chloride restores and maintains extracellular fluid volume and osmolality, while supporting membrane potential, nerve and muscle function, and acid-base balance.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Feb 24, 1988 Original approval · Type 5 - New Formulation or New Manufacturer
16 products under this application
  • DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER · DEXTROSE 5GM/100ML; SODIUM CHLORIDE 110MG/100ML · INJECTABLE, INJECTION · Prescription
  • DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER · DEXTROSE 10GM/100ML; SODIUM CHLORIDE 200MG/100ML · INJECTABLE, INJECTION · Prescription
  • DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER · DEXTROSE 2.5GM/100ML; SODIUM CHLORIDE 450MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER · DEXTROSE 5GM/100ML; SODIUM CHLORIDE 900MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • DEXTROSE 2.5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER · DEXTROSE 2.5GM/100ML; SODIUM CHLORIDE 200MG/100ML · INJECTABLE, INJECTION · Prescription
  • DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER · DEXTROSE 5GM/100ML; SODIUM CHLORIDE 450MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER · DEXTROSE 10GM/100ML; SODIUM CHLORIDE 900MG/100ML · INJECTABLE, INJECTION · Prescription
  • DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER · DEXTROSE 5GM/100ML; SODIUM CHLORIDE 200MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • DEXTROSE 10% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER · DEXTROSE 10GM/100ML; SODIUM CHLORIDE 330MG/100ML · INJECTABLE, INJECTION · Prescription
  • DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER · DEXTROSE 2.5GM/100ML; SODIUM CHLORIDE 900MG/100ML · INJECTABLE, INJECTION · Prescription
  • DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER · DEXTROSE 10GM/100ML; SODIUM CHLORIDE 110MG/100ML · INJECTABLE, INJECTION · Prescription
  • DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER · DEXTROSE 2.5GM/100ML; SODIUM CHLORIDE 330MG/100ML · INJECTABLE, INJECTION · Prescription
  • DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER · DEXTROSE 2.5GM/100ML; SODIUM CHLORIDE 110MG/100ML · INJECTABLE, INJECTION · Prescription
  • DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER · DEXTROSE 3.3GM/100ML; SODIUM CHLORIDE 300MG/100ML · INJECTABLE, INJECTION · Prescription
  • DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER · DEXTROSE 5GM/100ML; SODIUM CHLORIDE 330MG/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER · DEXTROSE 10GM/100ML; SODIUM CHLORIDE 450MG/100ML · INJECTABLE, INJECTION · Prescription

Clinical trials

Interventional ClinicalTrials.gov studies with "Dextrose" as an intervention, any sponsor and status, largest first.

All 3,797 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • vomiting40
  • nausea34
  • hyponatraemia28
  • sepsis28
  • ascites27
  • constipation27
  • abdominal distension26
  • abdominal pain26
  • off label use26
  • general physical health deterioration25
  • anaemia24
  • appendicitis24

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20052
20071
20081
20101
20122
20133
20144
201514
20169
20176
20189
20196
202012
202112
202225
202320
202423
20257
202610

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 1,414 on PubMed

Sponsor: B Braun · Also marketed as Dextrose 10% and Sodium Chloride 0.2% In Plastic Container, Dextrose 2.5% and Sodium Chloride 0.45% In Plastic Container, Dextrose 5% and Sodium Chloride 0.9% In Plastic Container, Dextrose 2.5% and Sodium Chloride 0.2% In Plastic Container, Dextrose 5% and Sodium Chloride 0.45% In Plastic Container

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.